comparemela.com

Latest Breaking News On - ஆராய்ச்சி சிகிச்சை - Page 1 : comparemela.com

Kiến nghị thử nghiệm áp dụng công nghệ laser điều trị COVID-19

“Bộ Khoa học và Công nghệ, Bộ Y tế nên xem xét đề xuất của Trung tâm Công nghệ Laser, Viện Ứng dụng Công nghệ về nghiên cứu, thử nghiệm áp dụng công nghệ laser hỗ trợ điều trị bệnh nhân Covid-19”, TSKH Phan Xuân Dũng, Chủ tịch Liên hiệp các Hội Khoa

14 nuevos títulos en la Universidad de Las Palmas de Gran Canaria – canariasactual com

14 nuevos títulos en la Universidad de Las Palmas de Gran Canaria – canariasactual com
canariasactual.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from canariasactual.com Daily Mail and Mail on Sunday newspapers.

BioBuzz celebrates Asian/Pacific American Heritage (AAPI) Month · BioBuzz

Asian/Pacific American Heritage (AAPI) Month is celebrated annually during the month of May. It marks the celebration of Asians and Pacific Islanders in the United States. It includes people having origins from the continent of Asia and the Pacific islands of Melanesia and Polynesia. Asian Americans and Pacific Islanders have a rich culture and heritage spanning thousands of years that have shaped the modern history of the US.  AAPI Heritage commemoration was first proposed in 1977 to observe the immigration of the first Japanese to the US (May 7, 1843) and the completion of the transcontinental railroad, constructed mainly by Chinese immigrant workers (May 10, 1869). President Carter made it an annual week-long event in 1978, and eventually, President George H.W. Bush extended the proclamation to include the entire month of May. 

BrainStorm Announces the Publication of Preclinical Data Highlighting the Potential of a NurOwn® Derived Exosome-Based Treatment for COVID-19 ARDS

Share this article Share this article NEW YORK, Jan. 20, 2021 /PRNewswire/  BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today the peer-reviewed publication of a preclinical study in the journal Stem Cell and Research Therapy. The study, entitled MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model, evaluated the use of NurOwn® (MSC-NTF cell) derived exosomes in a mouse model of acute respiratory distress syndrome (ARDS). ARDS is a type of respiratory failure that is frequently associated with COVID-19 and mediated by dysregulated cytokine production. While there are currently no effective therapies to prevent or reverse ARDS, mesenchymal stem cell (MSC)-derived exosomes have been suggested as a potential novel treatment option due to their ability to penetrate deep into tissues and efficiently deliver immunomodulatory molecules.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.